Targeting Tumor‐Associated Antigens in Hepatocellular Carcinoma for Immunotherapy: Past Pitfalls and Future Strategies

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hepatology (Baltimore, Md.) Md.), 2021-02, Vol.73 (2), p.821-832
Hauptverfasser:	Lu, Ligong, Jiang, Jun, Zhan, Meixiao, Zhang, Hui, Wang, Qian‐Ting, Sun, Sheng‐Nan, Guo, Xiao‐Kai, Yin, Hua, Wei, Yadong, Li, Shi‐You, Liu, Jun O., Li, Yong, He, You‐Wen
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigen (tumor-associated) Antigens, Neoplasm - metabolism Antineoplastic Agents, Immunological - pharmacology Antineoplastic Agents, Immunological - therapeutic use Cancer Vaccines - therapeutic use Carcinoma, Hepatocellular - genetics Carcinoma, Hepatocellular - immunology Carcinoma, Hepatocellular - mortality Carcinoma, Hepatocellular - therapy Clinical Trials as Topic Disease-Free Survival Gastroenterology & Hepatology Hepatocellular carcinoma Hepatology Humans Immunotherapy Immunotherapy - methods Immunotherapy - trends Life Sciences & Biomedicine Liver cancer Liver Neoplasms - genetics Liver Neoplasms - immunology Liver Neoplasms - mortality Liver Neoplasms - therapy Molecular Targeted Therapy - methods Molecular Targeted Therapy - trends Mutation Neoplasm Recurrence, Local - epidemiology Neoplasm Recurrence, Local - genetics Neoplasm Recurrence, Local - immunology Neoplasm Recurrence, Local - prevention & control Science & Technology T-Lymphocytes, Cytotoxic - drug effects T-Lymphocytes, Cytotoxic - immunology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!